Andreessen Horowitz October 15, 2024
Julie Yoo and Jay Rughani

Your access to life-saving medications shouldn’t depend on your zip code. Yet, for millions of Americans, especially in rural areas or lower-income communities, that is the reality.

Despite pharmaceutical spending in the US reaching over $700 billion each year, wide disparities in access to medications persist. The resulting inequities are particularly acute for rural communities and lower-income families, as well as for certain stigmatized populations such as those living with HIV or Hepatitis C (HCV).

Further, the clinics intended to serve these very groups, such as Federally Qualified Health Centers (FQHCs), Ryan White Clinics, and Sexually Transmitted Disease Clinics, often struggle to stay afloat financially. In particular, they lack the capabilities and capital needed to build and manage their own...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Pharma, Pharma / Biotech, Trends
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article